Skip to content
Sharism- Lifestyle
Author:
Insilico Medicine
Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial
March 6, 2026